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Abstract
The peritoneal mesothelium exhibits a high regenerative ability. Peritoneal regeneration is concomitant with the appearance, in the
coelomic cavity, of a free-floating population of cells whose origin and functions are still under discussion. We have isolated and char-
acterized this cell population and we have studied the process of mesothelial regeneration through flow cytometry and confocal
microscopy in a murine model lethally irradiated and reconstituted with GFP-expressing bone marrow cells. In unoperated control mice,
most free cells positive for mesothelin, a mesothelial marker, are green fluorescent protein (GFP). However, 24 hrs after peritoneal dam-
age, free mesothelin/ GFP cells appear in peritoneal lavages. Cultured lavage peritoneal cells show colocalization of GFP with
mesothelial (mesothelin, cytokeratin) and fibroblastic markers. Immunohistochemical staining of the peritoneal wall also revealed colo-
calization of GFP with mesothelial markers and with procollagen-1 and smooth muscle -actin. This was observed in the injured area
as well as in the surrounding not-injured peritoneal surfaces. These cells, which we herein call peritoneal repairing cells (PRC), are very
abundant 1 week after surgery covering both the damaged peritoneal wall and the surrounding uninjured area. However, they become
very scarce 1 month later, when the mesothelium has completely healed. We suggest that PRC constitute a type of monocyte-derived
cells, closely related with the tissue-repairing cells known as ‘fibrocytes’ and specifically involved in peritoneal reparation. Thus, our
results constitute a synthesis of the different scenarios hitherto proposed about peritoneal regeneration, particularly recruitment of cir-
culating progenitor cells and adhesion of free-floating coelomic cells.
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Introduction
Peritoneal regeneration is a very important issue from the clinical
point of view because of the unique physiological properties of the
mesothelium, the complications of the abdominal surgery due to
serosal adhesions and the disastrous consequences of continued
peritoneal dialysis for the mesothelial integrity [1, 2].
The peritoneal mesothelium exhibits a high regenerative ability.
The pioneering studies [3] described how peritoneal injuries were
able to heal at the same rate independently of their size. Thus, 
centripetal growth is not enough to account for peritoneal regen-
eration. The phenomenon was explained by the appearance,
immediately after a peritoneal injury, of a population of cells which
freely float in the peritoneal cavity and adhere to the damaged sur-
face (reviewed in [4]). However, the origin, nature and precise
functions of this population are still uncertain. Some studies have
suggested that these cells are peritoneal macrophages that either
promote mesothelial proliferation or directly can differentiate into
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mesothelial cells [5–8]. Other works provide evidence that free-
floating cells are just mesothelial cells which have delaminated
from other areas of the peritoneum and attach to the injured area
to recover their epithelial phenotype [9, 10]. Furthermore, recruit-
ment of sub-mesothelial fibroblast-like cells [11] or mobilization
of circulating progenitor cells [12] has also been claimed as a
regenerating mechanism.
We aimed to solve the long-lasting dispute about the origin and
the nature of the free-floating cells which appear after a peritoneal
damage and contribute to mesothelial regeneration by using a
murine model lethally irradiated and reconstituted with bone mar-
row cells from mice constitutively expressing enhanced GFP. We
have isolated and characterized the free-floating cell population
and we have studied the process of mesothelial regeneration
through confocal and scanning electron microscopy. We think that
our results constitute a synthesis of the above quoted scenarios
proposed about mesothelial regeneration, particularly adhesion of
free-floating cells to the damaged surface and recruitment of cir-
culating progenitor cells. We herein provide evidence that bone
marrow derived cells migrate into the mesothelial cell layer,
acquire a mesothelial-like phenotype and are released to the peri-
toneal cavity to constitute a free-floating, peritoneal repairing cell
population. Interestingly, these cells apparently attach not only to
the damaged surface, but also to adjacent areas.
Material and methods
Animals and haematopoietic bone marrow transplants
Eight- to 10-week-old B6.SJL-Ptprca/bPep3b/BoyJxDBA/2 mice
(P3D2F1; CD45.1/CD45.2 phenotype) were used as recipients of labelled
bone marrow cells. Breeding pairs, originally obtained from Jackson
Laboratories (Bar Harbor, ME, USA), were bred at the CIEMAT animal
facility (Registration number 28079–21A), allowed food and water 
ad libitum, and routinely screened for pathogens in accordance 
with FELASA (Federation of European Laboratory Animal Science
Associations) procedures. The F1 mice of C57BL/6J-actinEGFP
(enhanced green fluorescent protein) (kindly provided by Dr. M. Okabe,
Osaka, Japan) and DBA/2 mice (BDGF1; CD45.2 EGFP phenotype) were
used as donors of bone marrow cells. Recipients of bone marrow trans-
plants were irradiated with doses for a myeloablative regimen with a
Philips MG324 X-ray equipment (Philips, Hamburg, Germany) set at 300
kV, 10 mA, delivering a total dose 10 Gy, split in two doses, 4 hrs apart,
at a dose rate of 1.03 Gy/min.
Bone marrow cells were collected from 6-week-old BDGF1 male
mice by flushing tibias and femurs with Iscove’s modified Dulbecco’s
media (Gibco Laboratories, Grand Island, NY, USA). Bone marrow cell
viability was analysed by the Trypan Blue exclusion method. A total of
107 bone marrow cells were injected into 8- to 10-week-old lethally
irradiated female P3D2F1 mice. One and 3 months after transplanta-
tion, the haematopoietic engraftment in the peripheral blood was
analysed by flow cytometry by analysing the expression of the EGFP
and the specific CD45.1 and CD45.2 panleucocyte isoforms using 
specific monoclonal antibodies (BD Biosciences Pharmingen, San
Diego, CA, USA).
BALB/c mice were also used for some experiments not involving
labelled bone marrow cells.
Surgical procedure and peritoneal cell collection
Free-floating peritoneal cells were obtained by a modification of the pub-
lished procedure [10]. Briefly, mice were anaesthetized and opened in the
midline. Then, we provoked a slight, superficial abrasion on the right ante-
rior peritoneal wall with a sterile scalpel blade, taking care to avoid haem-
orrhage. Mice were allowed to recover from anaesthesia and returned to
housing. After 24 or 48 hrs the mice were killed by cervical dislocation and
the peritoneal cavity was rinsed with 10 ml PBS. Cells were collected by
centrifugation at 400  g for 5 min., and cultured or used immediately for
flow cytometry as described below.
Cell culture and flow cytometry
Collected cells from peritoneal lavage were cultured on plastic with DMEM
supplemented with 10% foetal bovine serum, penicillin/streptomycin at
37C and 5% CO2 in a humidified incubator. For positive control we used
mouse adult mesothelial cells obtained from explants of omentum on 
gelatine-coated cover slips.
For flow cytometry, collected cells were incubated on ice for 20 min.
with the primary antibody diluted in PBS supplemented with 1% foetal
bovine serum and 10 mM HEPES, centrifuged and resuspended in the
same buffer. Cells labelled with unlabelled or biotinylated primary antibod-
ies were incubated with the corresponding secondary antibody (usually
Cy5-conjugated donkey anti-rat IgG), centrifuged and resuspended again.
Negative controls were incubated with isotype IgG and then with the sec-
ondary antibody above described. Usually, cells were also incubated with
propidium iodide (25 g/ml) and negative cells were gated to eliminate
dead cells from the analysis. The analysis was performed in a DAKO-
Cytomation MoFlo Sorter (Dako, Glostrup, Denmark). The primary antibod-
ies used were: rat antimouse CD45, PE conjugated (Pharmigen, Becton
Dickinson, Franklin Lakes, NJ, USA, Clone 30-F11) diluted 1:500; rat anti-
mouse mesothelin (MBL D053, clone 295D; MBL, Woburn, MA, USA)
diluted 1:50; rat antimouse F4/80, FITC conjugated (eBioscience 11–4801,
Clone BM8; eBioscience, San Diego, CA, USA) diluted 1:100.
Histology and immunocytochemistry
Dissected fragments of the right (injured) and the left (intact contralateral)
peritoneal walls from mice killed 48 hrs, 1 week or 1 month after surgery
were fixed overnight at 4C in 4% paraformaldehyde (PFA) or at 20C in
Dent’s fixative (Metanol:DMSO 4:1). The tissue was cryoprotected in 15%
and 30% sucrose solution, snap frozen in liquid nitrogen-cooled isopen-
tane and embedded in optimal cutting temperature (OCT). Ten micrometre
sections were obtained in a cryostat. Fragments of the anterior peritoneal
wall of unoperated mice were used as controls.
Cultured cells were fixed for 20 min. at room temperature in 2% PFA or
for 20 min. at 20C in Dent’s fixative, washed in PBS and blocked with
16% sheep serum, 1% bovine serum albumin and 0.5% Triton X-100 in
Tris-PBS (SBT). Double immunolabelling was performed incubating with a
monoclonal and a polyclonal primary antibody at the same time, using the
corresponding secondary biotinylated and/or Cy5-conjugated antibodies
(1:100 in SBT) and incubating finally for 45 min. with a complementary flu-
orochrome–conjugated streptavidin (Sigma-Aldrich, St. Louis, MO, USA),
1:150 in PBS. Nuclei were usually counterstained with propidium iodide or
4	,6-diamidiino-2-phenylindole (DAPI). Colocalization of CD45 with cytok-
eratin required pre-incubation with a rat anti CD45-PE on live cells, exten-
sive wash and fixation with Cytofix (Becton Dickinson). After washing, the
sections were mounted in a 1:1 PBS/glycerol solution and analysed using
a Leica TCS SPE laser confocal microscope (Leica Microsystems, Wetzlar,
Germany). Primary antibodies used were: polyclonal rabbit anti-cytokeratin
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Fig. 1 Flow cytometry analysis of the cell population obtained by peritoneal lavage in control unoperated mice, 24 and 48 hrs after injury of the peritoneal
wall. Representative result from a series of experiments described in the text. Top row: Isotype control (rat IgG2a) versus GFP. About two thirds of the
cells present in the peritoneal lavage are GFP. Second row: Mesothelin versus GFP. In the unoperated mouse, 4.2% of the cells are mesothelin/GFP–.
They probably are delaminated mesothelial cells. Because these cells can be considered as a positive control of the antibody, we used this population to
establish the limit between the mesothelin and mesothelin– cells. According to this criterion, 16.6% and 6.3% of the cells were mesothelin/GFP by
24 and 48 hrs after surgery. Note the increase of mesothelin/GFP– cells by 24 hrs, reaching more than 10% of the total population. Bottom rows: Gating
on a F4/80/GFP population obtained from peritoneal lavages originates similar SS/FS profiles from unoperated and operated mice. However, gating on
the mesothelin/GFP population originates a different profile, suggesting that both populations are different.
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(DAKO, Z0622) diluted 1:200; polyclonal rabbit anti-fibroblast specific pro-
tein (FSP)1 (A kind gift from Dr. Eric Neilson, Vanderbilt University School
of Medicine) diluted 1:100; rat antimouse CD68 (AbD Serotec, Dusseldorf,
Germany, MCA1957BT, Clone FA-11) diluted 1:100; polyclonal rabbit anti-
mesothelin (A kind gift from Dr. Ira Pastan, NCI-NIH) diluted 1:200; mouse
anti-SMC -actin (Sigma A2547, Clone 1A4) diluted 1:200; goat polyclonal
anti-procollagen I (Santa Cruz, Biotechnologies, Heidelberg, Germany; SC-
8787) diluted 1:100.
Scanning electron microscopy
Samples of peritoneal walls were fixed in 1% paraformaldehyde, 1% 
glutaraldehyde in PBS (1 hr) and washed in bidistilled water. Then, the
samples were dehydrated in an ethanolic series finishing in 100 ethanol
and dried from liquid CO2 by the critical-point method whereas the cell
aggregates were air dried. Then all the samples were gold sputted (about
450Å) in a JEOL fine-coat ion sputter (JFC-1100), observed and pho-
tographed in a JEOL JSM-840 scanning electron microscope (JEOL,
Tokyo, Japan) operated between 10 and 20 kV.
RT-PCR
Total RNA was isolated from (1) the CD45 cell fraction of a peritoneal lavage
(48 hrs after surgery) purified with antimouse CD45-coated magnetic
immunobeads according to the manufacturer’s instructions (Miltenyi Biotec,
Bergisch Gladbach, Germany); (2) mouse mesothelial cells obtained by mild
trypsinization of the coelomic cavity and peritoneal lavage (positive control)
and (3) peritoneal lavage cells obtained from a mesothelin-null mouse [13]
(negative control). RNA was obtained with the RNAeasy MiniKit (Qiagen,
Hilden, Germany), following the manufacturer’s instructions. The yield and
quantification of RNA obtained was analysed with Nanodrop NP-100 (Thermo
Fisher Scientific, Waltham, MA, USA) and normalized to 1 g to RT-PCR.
Two-step RT-PCR was performed to mRNA amplification with oligo-dT
with the First Strand Amplification Kit (Roche Diagnostica, Barcelona,
Spain); normalization of RT-PCR product was made with expression of 
-actin as reference gene.
PCR amplification was performed with GoTaq Flexi polymerase
(Promega, Madison, WI, USA). Following pair of primers were used: 
5	 TCA GAG TCA TTG TTA TCC ACA GAC; 3	 AGT GTG GCC TCC TGG CTT GTC
TTT [13], with the following PCR program: 94C – 5 min.; 94C – 45 sec.,
60C – 45 sec., 72C – 45 sec., 35 cycles; 72C – 5 min.; and 4C – 5 min.
Results
Flow cytometry of peritoneal lavages after surgery
Peritoneal lavages obtained from mice 24 and 48 hrs after surgery
(n 
 1 and n 
 4, respectively), and from unoperated mice 
(n 
 3), were analysed by flow cytometry. Figure 1 shows the
results of a representative experiment. The top rows show the
detection of GFP and mesothelin in peritoneal lavage cells. About
two thirds of the peritoneal cells were GFP. Unoperated mice
show a population of mesothelin/GFP– cells accounting for 3.4%
of the total peritoneal lavage cells (n 
 3, s 
 0.74). These cells
increased their frequency to 10.4% in the only lavage obtained 
24 hrs after surgery, and they represented a 5.0% of the total 
48 hrs after surgery (n 
 4, s 
 1.48). On the other hand,
mesothelin/GFP cells were not clearly present in unoperated
mice, but a population these cells was found in 24 hrs (16.6% of
the total) and 48 hrs peritoneal lavages (6.1%, n 
 4, s 
 1.48).
Peritoneal macrophages, detected by F4/80 immunoreactivity,
accounted for a 6.8% of the total peritoneal lavage cells 48 hrs
after surgery (n 
 4, s 
 0.88). Virtually all F4/80 cells were
GFP. Gated mesothelin/GFP and F4/80 cells showed differ-
ent profiles in a FS/SS diagram, suggesting that they are different
populations (Fig. 1, bottom rows).
Detection of mesothelin by RT-PCR 
in the CD45 fraction
Mesothelin expression was confirmed by RT-PCR in the CD45
fraction obtained from a peritoneal lavage 48 hrs after peritoneal
injury and purified by magnetic immunobeads (Fig. 2). The ampli-
con size, 168 bp, was identical to that obtained from a positive
control consisting of mesothelial cells obtained from trypsiniza-
tion of the peritoneal cavity of an adult mouse. However, amplifi-
cation was not found in the negative control, trypsinized peritoneal
cells of a mesothelin-deficient mouse.
Immunohistochemistry of free peritoneal cells
Colocalization of mesothelial and leucocytic markers was frequent
in primary culture of cells obtained from peritoneal lavages 48 hrs
after injury, either from mice with GFP-expressing bone marrow or
from normal mice (Fig. 3). The colocalization was always found in
large, spindle-shaped cells. Cytokeratin showed a characteristic
perinuclear dot-like staining pattern (Fig. 3A, colocalization with
CD45). This pattern is frequent in primary cultures of mesothelial
cells, in which the cytokeratin cytoskeleton seems to collapse, as
shown in Figure 3(B), where some mesothelial cells show also the
Fig. 2 The CD45 fraction of the peritoneal lavage cells obtained 48 hrs
after injury of the peritoneal wall and purified by magnetic immunobeads,
shows mesothelin mRNA expression by RT-PCR. Positive control (C)
consisted of mesothelial cells obtained by mild trypsinization of the peri-
toneal cavity. Negative control (C–) was performed with free peritoneal
cells obtained from a mesothelin-null mouse. Normalization of RT-PCR
product was made with expression of -actin as reference gene.
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Fig. 3 Antigen immunolocalization in adherent cells obtained from peritoneal lavages 48 hrs after injury of the peritoneal wall. (A–C) show cells
obtained from normal BALB/c mice whereas (D)–(F) show cells from mice reconstituted with GFP-expressing bone marrow. (A) Virtually all the
CD45 cells show a perinuclear dot-like pattern of cytokeratin immunoreactivity. Note a strongly CD45–/cytokeratin immunoreactive cell, probably
a delaminated mesothelial cell (arrow). (B) The perinuclear dot-like pattern of cytokeratin immunoreactivity is also present in mesothelial cells
migrating from omentum explants, which were used as positive controls (arrows). Other cells still show an extended cytokeratin cytoskeleton
(arrowhead). (C) Mesothelin immunoreactivity colocalized with CD68. Note the cytoplasmic and perinuclear CD68 localization. (D) Triple localization
of mesothelin, cytokeratin and GFP. This immunostaining revealed different phenotypes, including triple positive cells (arrowheads),
mesothelin/cytokeratin, GFP– cells which probably are delaminated mesothelial cells (white arrows) and GFP, mesothelin–/cytokeratin– cells
(yellow arrow). (E) The fibroblast marker FSP1 was expressed in many GFP cells (white arrows), as well as in GFP– cells (yellow arrows). Other
GFP cells were negative for FSP1 (arrowhead). (F) Negative control incubated with isotype primary antibodies and with the same secondary anti-
bodies as used in the rest of the figures.
J. Cell. Mol. Med. Vol 15, No 5, 2011
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Fig. 4 Scanning electron microscopy of the peri-
toneal surface from a control, unoperated mouse
(A), from the injured area 48 hrs after surgery (B)
and from the contralateral area of the same mice
(C). A higher magnification of the latter is shown in
(D). The normal peritoneal surface is squamous
and shows abundant microvilli. In the injured sur-
face rounded cells covered by ruffles and microvilli
are present. Some cells show different degrees of
flattening (arrows). In the contralateral area shown
in (C), the surface shows areas of mesothelial acti-
vation, with the cells bulging in the lumen and
showing signs of detachment. These cells also
show microvilli, as shown in (D) (arrow).
perinuclear dot like pattern whereas others show a still well-developed
cytokeratin cytoskeleton (arrowhead in Fig. 3B). CD68 showed 
an intracytoplasmic pattern and colocalization with mesothelin
(Fig. 3C). In peritoneal cells obtained from mice with GFP-
expressing bone marrow, GFP colocalized with both mesothelin
and cytokeratin in some cells (arrowheads in Fig. 3D) whereas
others were GFP–/cytokeratin/mesothelin (white arrows in 
Fig. 3D). GFP also colocalized with the fibroblastic marker FSP1 in
part of the cells (Fig. 3E, E’). Negative control was incubated with
isotype IgG and the same secondary antibodies than in the other
slides (Fig. 3F).
Scanning electron microscopy
The injured peritoneal wall, after 48 hrs, showed extensive signs
of reparation, with cells adhered to the denudated surface and dis-
playing a variable degree of flattening (arrows in Fig. 4B).
Surprisingly the contralateral peritoneal surface (Fig. 4C and D)
showed a clear difference as compared with the control (unoper-
ated) mice (Fig. 4A) because of the presence of rounded cells,
loosely attached to the peritoneal surface. These features were
never observed in control unoperated mice.
Immunohistochemistry of peritoneal walls
After 48 hrs of the peritoneal injury, differences were conspicuous
between operated and unoperated mice. Surprisingly, signs of
mesothelial activation and remodelation were as intense in the
contralateral area as in the injured wall. In sections of peritoneal
walls from mice reconstituted with GFP bone marrow, GFP
cells were found in both, the injured and the contralateral peri-
toneal surfaces (Fig. 5), being slightly more abundant in the latter
(32.1% versus 26.1% of the total cell count; n 
 8, s 
 6.24 and
n 
 13, s 
 13.47, respectively). This difference was not statisti-
cally significant. GFP colocalized with mesothelin, especially in the
contralateral side and in round cells loosely attached to the peri-
toneal surface, where mesothelin immunoreactivity was very high
(Fig. 5A, C and D). These round cells, partially detached from the
peritoneum, were always absent in control, unoperated mice,
which only showed a few GFP cells inside the peritoneal wall but
never in the peritoneal lining (not shown). Intratisular GFP cells
from operated mice were always mesothelin– (Fig. 5B).
Colocalization of cytokeratin with GFP was again more evident in
the contralateral areas (Fig. 5F and G). To check the presence of
mature macrophages in the tissue we immunocolocalized the
F4/80 antigen with GFP. Only a few cells were positive, and they
were clearly distinct from the GFP cells adhered to the injured
surface (Fig. 5H and I). GFP/FSP1 cells were present in both,
the injured and contralateral areas (Fig. 5K and J). Finally, colocal-
ization of GFP with procollagen was also recorded in both, injured
and contralateral peritoneal walls (Fig. 5L and M). In normal mice
we also observed, 48 hrs after peritoneal damage, colocalization
of mesothelin and cytokeratin with CD45 and CD68 (not shown).
This colocalization was never found in control, unoperated mice.
One week after peritoneal damage, GFP cells were observed in
the peritoneal surface of both, the injured and the contralateral
areas. They were even more abundant than by 48 hrs, and they
formed several cell layers (Fig. 6). The proportion of GFP cells was
similar in both areas (55.7% in contralateral versus 57.7% in injured
areas; n 
 5, s 
 13.16 and n 
 6, s 
 9.92, respectively). GFP
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colocalized with cytokeratin (Fig. 6A, contralateral area) and smooth
muscle -actin (Fig. 6B and C, injured area). Cytokeratin staining
showed both the extended and the condensed dot-like pattern 
(Fig. 6A). One month after surgery, the mesothelial lining was again
normal, and the number of GFP cells had decreased considerably,
although it was still possible to find some GFP cells occasionally
Fig. 5 Colocalization of GFP and mesothelin, cytokeratin, F4/80, FSP1 and procollagen-1 in the injured (INJ) or contralateral (CL) peritoneal wall from
mice reconstituted with GFP-expressing bone marrow, 48 hrs after surgery. (A–D) Colocalization of GFP and mesothelin in the contralateral areas. Some
double-labelled cells are apparently detaching from the mesothelial surface (arrows). GFP cells within the tissue are mesothelin– as shown in (B).
GFP/mesothelin– cells are also abundant in sub-mesothelial areas (arrowheads). (E) Double labelled cells can also be seen in the regenerating mesothe-
lium of the injured surface (arrows). GFP/mesothelin– cells are also present but they are less abundant than in contralateral areas (arrowhead). (F), (G)
Colocalization of GFP and cytokeratin can be observed in the contralateral areas (arrows in F) but it is apparently scarcer in the injured ones (G).
GFP/cytokeratin– cells are shown in the contralateral side (arrowheads in F). (H), (I) The macrophage marker F4/80 is present in a few cells from both
areas (arrows). However, most of the apparently adhered GFP cells in the injured area do not express this macrophage marker (arrowheads). (J), (K)
Colocalization of GFP with the fibroblastic marker FSP1 (arrows). (L), (M) Colocalization of GFP with procollagen-1 (arrows).
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positive for cytokeratin and mesothelin, either at a sub-mesothelial
level or integrated in the mesothelial cell layer (Fig. 6D–F).
Discussion
The nature and origin of the peritoneal repairing cells (PRC) has
been subject of a long-lasting dispute. Delaminated mesothelial
cells, macrophages, resident mesenchymal or circulating progen-
itor cells have been alternatively claimed as main agents of the
peritoneal regeneration (reviewed in [4]). We think that our results
could clarify this point and provide an intermediate model in which
most of these points of view can be partially reconciled. According
to our findings, the process of peritoneal regeneration apparently
involves the recruitment, in the peritoneal wall and within the peri-
toneal cavity, of bone marrow derived cells which display expres-
sion of mesothelial markers (particularly mesothelin), and adhere
to the damaged surfaces. We will call this population PRC. These
cells have already been quoted by earlier works with different
names such as peritoneal exudative cells [14], or tissue repair
cells (TRC, [15, 16]), but a characterization of the origin or nature
of these cells was hitherto not performed. Most probably PRC are
also the same bone marrow derived cells, called ‘myofibroblasts’
and expressing SMC-actin, that cover fragments of silastic tub-
ing implants in the peritoneal cavity of mice [17].
PRC do not show the typical antigenic profile of mature peri-
toneal macrophages because we could not find colocalization of
F4/80 with mesothelial or fibroblastic markers although a signifi-
cant fraction of them expressed the antigen CD68 in the cyto-
plasm. The expression of another macrophage marker, CD11b, in
mesothelial cells during the early stages of development of pleu-
ral adhesions had previously been reported [8]. These antigenic
similarities with macrophages reveal a common lineage between
PRC and these cells, as monocyte-derived cells. Some reports
have emphasized the heterogeneity of the monocyte/macrophage
population not only in its antigenic profile but also in its differentia-
tion potential which seems to be much wider than supposed
Fig. 6 Colocalization of GFP, mesothelial and fibroblastic markers in the contralateral (CL) and injured (INJ) peritoneal wall from mice reconstituted with
GFP-expressing bone marrow, 1 week (A–C) and 1 month (D–F) after surgery. (A) Colocalization of cytokeratin and GFP in the injured area 1 week after
surgery. Some GFP cells show an extended cytokeratin cytoskeleton (arrowhead) whereas others show the perinuclear dot-like cytokeratin pattern
(arrows). (B), (C) Colocalization of smooth muscle cell -actin with GFP in the injured area 1 week after surgery. GFP cells are very abundant and form
several cell layers covering all the damaged area. Most of these cells express smooth muscle cell -actin. (D–F) Colocalization of mesothelial markers
and GFP in the injured and contralateral areas 1 month after surgery. The mesothelium is completely regenerated. GFP cells are present in the sub-
mesothelial area, and some of them show a perinuclear cytokeratin dot (arrows in D’). It is still possible to find a few GFP cells integrated in the mesothe-
lial lining of both, injured and contralateral areas, expressing cytokeratin (arrows in E) and mesothelin (arrows in F).
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[18–20]. However, we think that PRC are closely related to fibro-
cytes, a monocyte-derived cell type involved in processes of cell
repairing and fibrosis [21, 22]. Accordingly to the typical fibrocyte
description, PRC are large, spindle-shaped cells that express procol-
lagen-1 and SMC-actin, and they are rapidly recruited to sites of tis-
sue injury. As far as we know, the FSP1 protein, which is distinctly
expressed by PRC, had not been hitherto reported in fibrocytes.
However, PRC are different from the original description of fibrocytes
by the expression of mesothelial markers such as cytokeratin and
mesothelin. On the other hand, fibrocytes express CD34, a marker
which was not found in PRC by flow cytometry (data not shown).
However, we must be cautious when comparing antigenic analysis of
free-floating peritoneal cells with cells obtained from tissues,
because the antigenic profile can be modulated by their different
localization. Thus, despite minor antigenic differences, PRC could be
regarded as a specialized type of fibrocyte specifically involved in
peritoneal regeneration. Table 1 shows a comparison of the antigenic
profile of PRC, fibrocytes, fibroblasts and macrophages based on our
data and those published elsewhere [23].
Besides the active reparation process of the injured peritoneal
surface, we have observed striking changes in the contralateral
peritoneal wall 48 hrs after injury. The activation of uninjured
peritoneal areas surrounding the damaged mesothelium had
been previously described [24]. It is possible that, as described
elsewhere [10], during the earliest stages of peritoneal regener-
ation mesothelial cells can be released from uninjured areas to
adhere to the damaged ones. This is consistent with our obser-
vation of an increase of free GFP–/mesothelin cells in the peri-
toneal cavity 24 hrs after surgery. The subsequent denudation
would be repaired by recruitment of bone marrow derived PRC.
An alternative explanation is that the supposedly uninjured areas
spontaneously lose their mesothelial lining due to surgery.
Anyhow, the repairing mechanism mediated by PRC would
account for the similar number of these cells found in both, the
injured and contralateral areas even 1 week after surgery. PRC
would replace the lost mesothelium at both sides, and then they
probably are released into the peritoneal cavity. In fact, the char-
acteristic dot-like pattern of cytokeratin immunoreactivity of PRC
in culture is typical of epithelial cells which have transformed to
a mesenchymal state, a cellular process what involves the col-
lapse of the cytokeratin cytoskeleton. This can be observed in
cultured mesothelial cells (Fig. 3B) and it has also been
described in some epithelial-derived tumour lines [25]. The PRC-
derived mesothelial-like lining seems to be provisional, being
probably replaced by the proliferating mesothelium, as sug-
gested by the little number of GFP cells found in the mesothe-
lium 1 month after surgery.
Mesothelin is a cell surface glycoprotein widely expressed by
mesothelial cells. The pro-mesothelin peptide is proteolitically
cleaved by furin giving rise to the secreted MPF (megakaryocyte
potentiating factor) and the mature mesothelin, whose physiologi-
cal function is little known [26]. In fact, mice lacking mesothelin
expression are viable and fertile [13]. Giving the sharp increase in
mesothelin expression observed during peritoneal regeneration and
its proposed role as an adhesion molecule [27, 28], it is conceivable
that the physiological function of this protein could be related with
the control of the release and adhesion of the free-floating cells, 
critical processes for the mesothelial regeneration.
In summary, we think that most current and confronted points
of view about peritoneal regeneration can be reconciled by the
PRC concept, a new cell type, probably a monocyte-derived spe-
cialized subtype of fibrocyte, which express mesothelial, fibrob-
lastic, leucocytic and macrophage markers. We also think that the
potential of the PRC in tissue regeneration will deserve further
attention, given the plasticity reported for the adult mesothelial
cells [29, 30]. In this way PRC could be involved not only in the
regeneration of the peritoneal mesothelium but also in other con-
comitant processes of visceral tissue repair.
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Table 1 Expression of markers on macrophages, PRC, fibrocytes
and fibroblasts according our own results and data from [23]
NT: Not tested; –: No expression; , ,VAR: Low, high and variable
expression, respectively.
Antigen Macrophages PRC Fibrocytes Fibroblasts
CD45    –
CD68    
F4/80 VAR – – –
CD34 VAR – VAR –
Mesothelin –  – –
Cytokeratin –  – –
SMC-actin –  VAR VAR
FSP1 NT  NT 
Procollagen-1    
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